Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BMS Spends $100m On Orum’s Antibody-Guided Protein Degrader

07 Nov 2023

• By Elizabeth Cairns

Closeup Of Handshake — • Source: Shutterstock

Related Content

Orum Taking Novel ADC Approach To Protein Degradation

29 Jun 2021

It’s Official: The Merck-Daiichi Deal Has The Biggest Upfront Ever

23 Oct 2023

Related Companies

Bristol Myers Squibb Company

Orum Therapeutics

Pfizer Inc.

Monte Rosa Therapeutics, Inc.

Tubulis GmbH

Merck & Co., Inc.

Daiichi Sankyo Co., Ltd.

Seagen Inc.

Nurix Therapeutics, Inc.

Additional Topics

Deals Companies Research & Development Commercial Cancer Oncology BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.